Victor E. Tedesco V

Texas Heart Institute Positions

Education

  • Undergraduate:

    Louisiana State University

  • Graduate:

    University of Houston

Publications

4862227 N5HQ4VYL 1 alternatives-to-animal-experimentation 10 date desc Tedesco V 38650 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%222NEUX2CW%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kiang%20et%20al.%22%2C%22parsedDate%22%3A%222022-10-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKiang%2C%20S.%2C%20Nissim%2C%20L.%2C%20Tedesco%2C%20V.%20et%20al.%20%282022%29.%20Modeling%20a%20magnetic%20levitation%20bearing%20with%20CFD%20hemocompatibility%20optimization.%20In%20%26lt%3Bi%26gt%3B2022%20IEEE%2020th%20Biennial%20Conference%20on%20Electromagnetic%20Field%20Computation%20%28CEFC%29%26lt%3B%5C%2Fi%26gt%3B%20%281%26%23x2013%3B2%29.%20Denver%2C%20CO%2C%20USA%3A%20IEEE.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1109%5C%2FCEFC55061.2022.9940768%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1109%5C%2FCEFC55061.2022.9940768%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22conferencePaper%22%2C%22title%22%3A%22Modeling%20a%20magnetic%20levitation%20bearing%20with%20CFD%20hemocompatibility%20optimization%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Kiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Nissim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Tedesco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eiji%22%2C%22lastName%22%3A%22Ogiwara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Fraser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nobuyuki%22%2C%22lastName%22%3A%22Kurita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.H.%22%2C%22lastName%22%3A%22Frazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yaxin%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Oct%2024%202022%22%2C%22proceedingsTitle%22%3A%222022%20IEEE%2020th%20Biennial%20Conference%20on%20Electromagnetic%20Field%20Computation%20%28CEFC%29%22%2C%22conferenceName%22%3A%222022%20IEEE%2020th%20Biennial%20Conference%20on%20Electromagnetic%20Field%20Computation%20%28CEFC%29%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1109%5C%2FCEFC55061.2022.9940768%22%2C%22ISBN%22%3A%22978-1-66546-833-6%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fieeexplore.ieee.org%5C%2Fdocument%5C%2F9940768%5C%2F%22%2C%22collections%22%3A%5B%22SE7HDD49%22%2C%224IAB3NJ4%22%2C%22N5HQ4VYL%22%2C%22QF52JASW%22%5D%2C%22dateModified%22%3A%222022-12-01T19%3A18%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22CWMBCLQ7%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cocha%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCocha%2C%20G.%2C%20Tedesco%2C%20V.%2C%20D%26%23x2019%3BAttellis%2C%20C.%20et%20al.%20%282021%29.%20An%20algorithm%20mimicking%20pancreas%20pulsatile%20behavior%20improves%20artificial%20pancreas%20performance.%20%26lt%3Bi%26gt%3BInt%20J%20Artif%20Organs%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B44%26lt%3B%5C%2Fi%26gt%3B%2C%20756%26%23x2013%3B764.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F03913988211027176%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F03913988211027176%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20algorithm%20mimicking%20pancreas%20pulsatile%20behavior%20improves%20artificial%20pancreas%20performance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillermo%22%2C%22lastName%22%3A%22Cocha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Tedesco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22D%27Attellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Amorena%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Artificial%20pancreas%20design%20using%20subcutaneous%20insulin%20infusion%20without%20pre-meal%20feed-forward%20boluses%20often%20induces%20an%20over-response%20leading%20to%20hypoglycemia%20due%20to%20the%20increase%20of%20blood%20insulin%20concentration%20sustained%20in%20time.%20The%20objective%20of%20this%20work%20was%20to%20create%20an%20algorithm%20for%20controlling%20the%20function%20of%20insulin%20pumps%20in%20closed-loop%20systems%20to%20improve%20blood%20glucose%20management%20in%20type%201%20diabetic%20patients%20by%20mimicking%20the%20pulsatile%20behaviour%20of%20the%20pancreas.%5CnMETHODS%3A%20A%20controller%20tuned%20in%20a%20pulsatile%20way%20promotes%20damped%20oscillations%20of%20blood%20insulin%20concentration%20injected%20through%20an%20insulin%20pump.%20We%20tested%20it%20in%20a%20simulated%20environment%2C%20using%20nine%20%26%23039%3Bin%20silica%26%23039%3B%20subjects.%20The%20control%20algorithm%20is%20founded%20on%20feedback%20linearization%20where%20through%20a%20change%20of%20variables%2C%20the%20nonlinear%20system%20turns%20into%20an%20equivalent%20linear%20system%2C%20suitable%20for%20implementing%20through%20a%20PID%20controller.%20We%20compared%20the%20results%20obtained%20%26%23039%3Bin%20silica%26%23039%3B%20with%20the%20volume%20injected%20by%20an%20insulin%20pump%20controlled%20by%20this%20algorithm.%5CnRESULTS%3A%20The%20use%20of%20this%20algorithm%20resulted%20in%20a%20pulsatile%20control%20of%20postprandial%20blood%20glucose%20concentration%2C%20avoiding%20hypoglycaemic%20episodes.%20The%20results%20obtained%20%26%23039%3Bin%20silica%26%23039%3B%20were%20replicated%20in%20a%20real%20pump%20%26%23039%3Bin%20vitro%26%23039%3B.%5CnCONCLUSIONS%3A%20With%20this%20proposed%20linear%20system%2C%20an%20appropriate%20control%20input%20can%20be%20designed.%20The%20controller%20works%20with%20a%20damped%20pulsatile%20pattern%20making%20the%20insulin%20infusion%20from%20the%20pump%20and%20blood%20insulin%20concentration%20pulsatile.%20This%20operational%20would%20improve%20the%20performance%20of%20an%20artificial%20pancreas.%22%2C%22date%22%3A%222021-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F03913988211027176%22%2C%22ISSN%22%3A%221724-6040%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22N5HQ4VYL%22%5D%2C%22dateModified%22%3A%222022-03-02T22%3A20%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22HRVDRCV4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tedesco%20and%20Mohan%22%2C%22parsedDate%22%3A%222021-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BTedesco%2C%20V.%20E.%20and%20Mohan%2C%20C.%20%282021%29.%20Biomarkers%20for%20Predicting%20Cytokine%20Release%20Syndrome%20following%20CD19-Targeted%20CAR%20T%20Cell%20Therapy.%20%26lt%3Bi%26gt%3BJ%20Immunol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B206%26lt%3B%5C%2Fi%26gt%3B%2C%201561%26%23x2013%3B1568.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4049%5C%2Fjimmunol.2001249%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4049%5C%2Fjimmunol.2001249%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Biomarkers%20for%20Predicting%20Cytokine%20Release%20Syndrome%20following%20CD19-Targeted%20CAR%20T%20Cell%20Therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%20E.%22%2C%22lastName%22%3A%22Tedesco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandra%22%2C%22lastName%22%3A%22Mohan%22%7D%5D%2C%22abstractNote%22%3A%22Chimeric%20Ag%20receptor%20%28CAR%29%20T%20cell%20therapy%20has%20shown%20astonishing%20potency%20in%20treating%20a%20variety%20of%20hematological%20malignancies%20in%20recent%20years.%20Along%20with%20this%20lifesaving%20potential%20comes%20the%20life-threatening%20toxicities%20of%20cytokine%20release%20syndrome%20%28CRS%29%20and%20neurotoxicity.%20This%20work%20seeks%20to%20consolidate%20biomarker%20candidates%20with%20the%20potential%20to%20predict%20the%20severity%20of%20CRS%20and%20neurotoxicity%20in%20patients%20receiving%20CD19-targeted%20CAR%20T%20cell%20therapy.%20In%20this%20systematic%20review%2C%2033%20clinical%20trials%20were%20evaluated%20for%20biomarkers%20that%20can%20predict%20the%20severity%20of%20posttreatment%20CRS%20and%20neurotoxicity.%20CRS%20and%20neurotoxicity%20occurred%20in%2073.4%20and%2037%25%20of%20the%20reviewed%20patients%2C%20respectively.%20Identified%20biomarker%20candidates%20included%20tumor%20burden%2C%20platelet%20count%2C%20C-reactive%20protein%2C%20ferritin%2C%20IFN-%5Cu03b3%2C%20IL-2%2C%20IL-6%2C%20IL-8%2C%20IL-10%2C%20IL-15%2C%20and%20TGF-%5Cu03b2.%20Combinatorial%20algorithms%20based%20on%20cytokine%20levels%20and%20clinical%20parameters%20show%20excellent%20promise%20in%20predicting%20CAR-T-cell-therapy-associated%20toxicities%2C%20with%20improved%20accuracy%20over%20the%20component%20biomarkers.%22%2C%22date%22%3A%222021-04-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.4049%5C%2Fjimmunol.2001249%22%2C%22ISSN%22%3A%221550-6606%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22N5HQ4VYL%22%5D%2C%22dateModified%22%3A%222022-03-02T22%3A20%3A34Z%22%7D%7D%2C%7B%22key%22%3A%225GE3SQZ4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tedesco%20and%20Tedesco%22%2C%22parsedDate%22%3A%222017-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BTedesco%2C%20A.%20E.%20and%20Tedesco%2C%20V.%20E.%20%282017%29.%20Pledget%20Induced%20Cardiogenic%20Shock%20Following%20a%20Minimally%20Invasive%20Aortic%20Valve%20Replacement.%20%26lt%3Bi%26gt%3BJ%20La%20State%20Med%20Soc%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B169%26lt%3B%5C%2Fi%26gt%3B%2C%2094%26%23x2013%3B95%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pledget%20Induced%20Cardiogenic%20Shock%20Following%20a%20Minimally%20Invasive%20Aortic%20Valve%20Replacement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%20E.%22%2C%22lastName%22%3A%22Tedesco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%20E.%22%2C%22lastName%22%3A%22Tedesco%22%7D%5D%2C%22abstractNote%22%3A%22Within%20the%20last%20decade%2C%20minimally%20invasive%20valve%20replacements%20have%20become%20exceedingly%20popular%2C%20and%20as%20a%20result%2C%20so%20has%20the%20rise%20of%20technology%20aimed%20at%20refining%20and%20simplifying%20these%20techniques.%20With%20new%20technology%2C%20new%20complications%20are%20inevitable.%20We%20present%20a%20routine%20Minimally%20invasive%20aortic%20valve%20replacement%20through%20a%20right%20anterior%20minithoracotomy%20complicated%20by%20pledget%20impaction%20in%20a%20coronary%20artery.%22%2C%22date%22%3A%222017%20Jul-Aug%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220024-6921%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22N5HQ4VYL%22%5D%2C%22dateModified%22%3A%222022-03-02T22%3A20%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22SKN8NEW5%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reardon%20et%20al.%22%2C%22parsedDate%22%3A%222017-04-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BReardon%2C%20M.%20J.%2C%20Van%20Mieghem%2C%20N.%20M.%2C%20Popma%2C%20J.%20J.%20et%20al.%20%282017%29.%20Surgical%20or%20Transcatheter%20Aortic-Valve%20Replacement%20in%20Intermediate-Risk%20Patients.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B376%26lt%3B%5C%2Fi%26gt%3B%2C%201321%26%23x2013%3B1331.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1700456%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1700456%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Surgical%20or%20Transcatheter%20Aortic-Valve%20Replacement%20in%20Intermediate-Risk%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%20M.%22%2C%22lastName%22%3A%22Van%20Mieghem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20J.%22%2C%22lastName%22%3A%22Popma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20S.%22%2C%22lastName%22%3A%22Kleiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lars%22%2C%22lastName%22%3A%22S%5Cu00f8ndergaard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mubashir%22%2C%22lastName%22%3A%22Mumtaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20H.%22%2C%22lastName%22%3A%22Adams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Michael%22%2C%22lastName%22%3A%22Deeb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brijeshwar%22%2C%22lastName%22%3A%22Maini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hemal%22%2C%22lastName%22%3A%22Gada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanley%22%2C%22lastName%22%3A%22Chetcuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Gleason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Heiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00fcdiger%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Merhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20K.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20S.%22%2C%22lastName%22%3A%22Olsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolo%22%2C%22lastName%22%3A%22Piazza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathew%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%22%2C%22lastName%22%3A%22Windecker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20J.%22%2C%22lastName%22%3A%22Yakubov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eberhard%22%2C%22lastName%22%3A%22Grube%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raj%22%2C%22lastName%22%3A%22Makkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joon%20S.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Conte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Vang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hang%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanping%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20S.%22%2C%22lastName%22%3A%22Mugglin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20W.%20J.%20C.%22%2C%22lastName%22%3A%22Serruys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arie%20P.%22%2C%22lastName%22%3A%22Kappetein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22SURTAVI%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Although%20transcatheter%20aortic-valve%20replacement%20%28TAVR%29%20is%20an%20accepted%20alternative%20to%20surgery%20in%20patients%20with%20severe%20aortic%20stenosis%20who%20are%20at%20high%20surgical%20risk%2C%20less%20is%20known%20about%20comparative%20outcomes%20among%20patients%20with%20aortic%20stenosis%20who%20are%20at%20intermediate%20surgical%20risk.%5CnMETHODS%3A%20We%20evaluated%20the%20clinical%20outcomes%20in%20intermediate-risk%20patients%20with%20severe%2C%20symptomatic%20aortic%20stenosis%20in%20a%20randomized%20trial%20comparing%20TAVR%20%28performed%20with%20the%20use%20of%20a%20self-expanding%20prosthesis%29%20with%20surgical%20aortic-valve%20replacement.%20The%20primary%20end%20point%20was%20a%20composite%20of%20death%20from%20any%20cause%20or%20disabling%20stroke%20at%2024%20months%20in%20patients%20undergoing%20attempted%20aortic-valve%20replacement.%20We%20used%20Bayesian%20analytical%20methods%20%28with%20a%20margin%20of%200.07%29%20to%20evaluate%20the%20noninferiority%20of%20TAVR%20as%20compared%20with%20surgical%20valve%20replacement.%5CnRESULTS%3A%20A%20total%20of%201746%20patients%20underwent%20randomization%20at%2087%20centers.%20Of%20these%20patients%2C%201660%20underwent%20an%20attempted%20TAVR%20or%20surgical%20procedure.%20The%20mean%20%28%5Cu00b1SD%29%20age%20of%20the%20patients%20was%2079.8%5Cu00b16.2%20years%2C%20and%20all%20were%20at%20intermediate%20risk%20for%20surgery%20%28Society%20of%20Thoracic%20Surgeons%20Predicted%20Risk%20of%20Mortality%2C%204.5%5Cu00b11.6%25%29.%20At%2024%20months%2C%20the%20estimated%20incidence%20of%20the%20primary%20end%20point%20was%2012.6%25%20in%20the%20TAVR%20group%20and%2014.0%25%20in%20the%20surgery%20group%20%2895%25%20credible%20interval%20%5BBayesian%20analysis%5D%20for%20difference%2C%20-5.2%20to%202.3%25%3B%20posterior%20probability%20of%20noninferiority%2C%20%26gt%3B0.999%29.%20Surgery%20was%20associated%20with%20higher%20rates%20of%20acute%20kidney%20injury%2C%20atrial%20fibrillation%2C%20and%20transfusion%20requirements%2C%20whereas%20TAVR%20had%20higher%20rates%20of%20residual%20aortic%20regurgitation%20and%20need%20for%20pacemaker%20implantation.%20TAVR%20resulted%20in%20lower%20mean%20gradients%20and%20larger%20aortic-valve%20areas%20than%20surgery.%20Structural%20valve%20deterioration%20at%2024%20months%20did%20not%20occur%20in%20either%20group.%5CnCONCLUSIONS%3A%20TAVR%20was%20a%20noninferior%20alternative%20to%20surgery%20in%20patients%20with%20severe%20aortic%20stenosis%20at%20intermediate%20surgical%20risk%2C%20with%20a%20different%20pattern%20of%20adverse%20events%20associated%20with%20each%20procedure.%20%28Funded%20by%20Medtronic%3B%20SURTAVI%20ClinicalTrials.gov%20number%2C%20NCT01586910%20.%29.%22%2C%22date%22%3A%222017-04-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa1700456%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22N5HQ4VYL%22%5D%2C%22dateModified%22%3A%222022-03-02T22%3A20%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22TSBBDPJ2%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Popma%20et%20al.%22%2C%22parsedDate%22%3A%222014-05-20%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPopma%2C%20J.%20J.%2C%20Adams%2C%20D.%20H.%2C%20Reardon%2C%20M.%20J.%20et%20al.%20%282014%29.%20Transcatheter%20aortic%20valve%20replacement%20using%20a%20self-expanding%20bioprosthesis%20in%20patients%20with%20severe%20aortic%20stenosis%20at%20extreme%20risk%20for%20surgery.%20%26lt%3Bi%26gt%3BJ%20Am%20Coll%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%201972%26%23x2013%3B1981.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2014.02.556%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2014.02.556%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20aortic%20valve%20replacement%20using%20a%20self-expanding%20bioprosthesis%20in%20patients%20with%20severe%20aortic%20stenosis%20at%20extreme%20risk%20for%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20J.%22%2C%22lastName%22%3A%22Popma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20H.%22%2C%22lastName%22%3A%22Adams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20J.%22%2C%22lastName%22%3A%22Yakubov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20S.%22%2C%22lastName%22%3A%22Kleiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Heimansohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Hermiller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Chad%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Kevin%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Diez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Kafi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodore%22%2C%22lastName%22%3A%22Schreiber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20G.%22%2C%22lastName%22%3A%22Gleason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Conte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurice%22%2C%22lastName%22%3A%22Buchbinder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Michael%22%2C%22lastName%22%3A%22Deeb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Blas%5Cu00e9%22%2C%22lastName%22%3A%22Carabello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20W.%22%2C%22lastName%22%3A%22Serruys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharla%22%2C%22lastName%22%3A%22Chenoweth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20K.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CoreValve%20United%20States%20Clinical%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20This%20study%20sought%20to%20evaluate%20the%20safety%20and%20efficacy%20of%20the%20CoreValve%20transcatheter%20heart%20valve%20%28THV%29%20for%20the%20treatment%20of%20severe%20aortic%20stenosis%20in%20patients%20at%20extreme%20risk%20for%20surgery.%5CnBACKGROUND%3A%20Untreated%20severe%20aortic%20stenosis%20is%20a%20progressive%20disease%20with%20a%20poor%20prognosis.%20Transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20with%20a%20self-expanding%20bioprosthesis%20is%20a%20potentially%20effective%20therapy.%5CnMETHODS%3A%20We%20performed%20a%20prospective%2C%20multicenter%2C%20nonrandomized%20investigation%20evaluating%20the%20safety%20and%20efficacy%20of%20self-expanding%20TAVR%20in%20patients%20with%20symptomatic%20severe%20aortic%20stenosis%20with%20prohibitive%20risks%20for%20surgery.%20The%20primary%20endpoint%20was%20a%20composite%20of%20all-cause%20mortality%20or%20major%20stroke%20at%2012%20months%2C%20which%20was%20compared%20with%20a%20pre-specified%20objective%20performance%20goal%20%28OPG%29.%5CnRESULTS%3A%20A%20total%20of%2041%20sites%20in%20the%20United%20States%20recruited%20506%20patients%2C%20of%20whom%20489%20underwent%20attempted%20treatment%20with%20the%20CoreValve%20THV.%20The%20rate%20of%20all-cause%20mortality%20or%20major%20stroke%20at%2012%20months%20was%2026.0%25%20%28upper%202-sided%2095%25%20confidence%20bound%3A%2029.9%25%29%20versus%2043.0%25%20with%20the%20OPG%20%28p%20%26lt%3B%200.0001%29.%20Individual%2030-day%20and%2012-month%20events%20included%20all-cause%20mortality%20%288.4%25%20and%2024.3%25%2C%20respectively%29%20and%20major%20stroke%20%282.3%25%20and%204.3%25%2C%20respectively%29.%20Procedural%20events%20at%2030%20days%20included%20life-threatening%5C%2Fdisabling%20bleeding%20%2812.7%25%29%2C%20major%20vascular%20complications%20%288.2%25%29%2C%20and%20need%20for%20permanent%20pacemaker%20placement%20%2821.6%25%29.%20The%20frequency%20of%20moderate%20or%20severe%20paravalvular%20aortic%20regurgitation%20was%20lower%2012%20months%20after%20self-expanding%20TAVR%20%284.2%25%29%20than%20at%20discharge%20%2810.7%25%3B%20p%20%3D%200.004%20for%20paired%20analysis%29.%5CnCONCLUSIONS%3A%20TAVR%20with%20a%20self-expanding%20bioprosthesis%20was%20safe%20and%20effective%20in%20patients%20with%20symptomatic%20severe%20aortic%20stenosis%20at%20prohibitive%20risk%20for%20surgical%20valve%20replacement.%20%28Safety%20and%20Efficacy%20Study%20of%20the%20Medtronic%20CoreValve%20System%20in%20the%20Treatment%20of%20Symptomatic%20Severe%20Aortic%20Stenosis%20in%20High%20Risk%20and%20Very%20High%20Risk%20Subjects%20Who%20Need%20Aortic%20Valve%20Replacement%3B%20NCT01240902%29.%22%2C%22date%22%3A%22May%2020%2C%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacc.2014.02.556%22%2C%22ISSN%22%3A%221558-3597%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22YL3LPZGE%22%2C%22B2JSS4XR%22%2C%22N5HQ4VYL%22%5D%2C%22dateModified%22%3A%222022-03-08T19%3A34%3A33Z%22%7D%7D%2C%7B%22key%22%3A%2272F38CCQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Adams%20et%20al.%22%2C%22parsedDate%22%3A%222014-05-08%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAdams%2C%20D.%20H.%2C%20Popma%2C%20J.%20J.%2C%20Reardon%2C%20M.%20J.%20et%20al.%20%282014%29.%20Transcatheter%20aortic-valve%20replacement%20with%20a%20self-expanding%20prosthesis.%20%26lt%3Bi%26gt%3BN%20Engl%20J%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B370%26lt%3B%5C%2Fi%26gt%3B%2C%201790%26%23x2013%3B1798.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1400590%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa1400590%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20aortic-valve%20replacement%20with%20a%20self-expanding%20prosthesis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20H.%22%2C%22lastName%22%3A%22Adams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20J.%22%2C%22lastName%22%3A%22Popma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20J.%22%2C%22lastName%22%3A%22Yakubov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Michael%22%2C%22lastName%22%3A%22Deeb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20G.%22%2C%22lastName%22%3A%22Gleason%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurice%22%2C%22lastName%22%3A%22Buchbinder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Hermiller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%20S.%22%2C%22lastName%22%3A%22Kleiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stan%22%2C%22lastName%22%3A%22Chetcuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Heiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Merhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Zorn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Tadros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Newell%22%2C%22lastName%22%3A%22Robinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Petrossian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Chad%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Kevin%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Conte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brijeshwar%22%2C%22lastName%22%3A%22Maini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mubashir%22%2C%22lastName%22%3A%22Mumtaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharla%22%2C%22lastName%22%3A%22Chenoweth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20K.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22U.S.%20CoreValve%20Clinical%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20We%20compared%20transcatheter%20aortic-valve%20replacement%20%28TAVR%29%2C%20using%20a%20self-expanding%20transcatheter%20aortic-valve%20bioprosthesis%2C%20with%20surgical%20aortic-valve%20replacement%20in%20patients%20with%20severe%20aortic%20stenosis%20and%20an%20increased%20risk%20of%20death%20during%20surgery.%5CnMETHODS%3A%20We%20recruited%20patients%20with%20severe%20aortic%20stenosis%20who%20were%20at%20increased%20surgical%20risk%20as%20determined%20by%20the%20heart%20team%20at%20each%20study%20center.%20Risk%20assessment%20included%20the%20Society%20of%20Thoracic%20Surgeons%20Predictor%20Risk%20of%20Mortality%20estimate%20and%20consideration%20of%20other%20key%20risk%20factors.%20Eligible%20patients%20were%20randomly%20assigned%20in%20a%201%3A1%20ratio%20to%20TAVR%20with%20the%20self-expanding%20transcatheter%20valve%20%28TAVR%20group%29%20or%20to%20surgical%20aortic-valve%20replacement%20%28surgical%20group%29.%20The%20primary%20end%20point%20was%20the%20rate%20of%20death%20from%20any%20cause%20at%201%20year%2C%20evaluated%20with%20the%20use%20of%20both%20noninferiority%20and%20superiority%20testing.%5CnRESULTS%3A%20A%20total%20of%20795%20patients%20underwent%20randomization%20at%2045%20centers%20in%20the%20United%20States.%20In%20the%20as-treated%20analysis%2C%20the%20rate%20of%20death%20from%20any%20cause%20at%201%20year%20was%20significantly%20lower%20in%20the%20TAVR%20group%20than%20in%20the%20surgical%20group%20%2814.2%25%20vs.%2019.1%25%29%2C%20with%20an%20absolute%20reduction%20in%20risk%20of%204.9%20percentage%20points%20%28upper%20boundary%20of%20the%2095%25%20confidence%20interval%2C%20-0.4%3B%20P%26lt%3B0.001%20for%20noninferiority%3B%20P%20%3D%200.04%20for%20superiority%29.%20The%20results%20were%20similar%20in%20the%20intention-to-treat%20analysis.%20In%20a%20hierarchical%20testing%20procedure%2C%20TAVR%20was%20noninferior%20with%20respect%20to%20echocardiographic%20indexes%20of%20valve%20stenosis%2C%20functional%20status%2C%20and%20quality%20of%20life.%20Exploratory%20analyses%20suggested%20a%20reduction%20in%20the%20rate%20of%20major%20adverse%20cardiovascular%20and%20cerebrovascular%20events%20and%20no%20increase%20in%20the%20risk%20of%20stroke.%5CnCONCLUSIONS%3A%20In%20patients%20with%20severe%20aortic%20stenosis%20who%20are%20at%20increased%20surgical%20risk%2C%20TAVR%20with%20a%20self-expanding%20transcatheter%20aortic-valve%20bioprosthesis%20was%20associated%20with%20a%20significantly%20higher%20rate%20of%20survival%20at%201%20year%20than%20surgical%20aortic-valve%20replacement.%20%28Funded%20by%20Medtronic%3B%20U.S.%20CoreValve%20High%20Risk%20Study%20ClinicalTrials.gov%20number%2C%20NCT01240902.%29.%22%2C%22date%22%3A%22May%2008%2C%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa1400590%22%2C%22ISSN%22%3A%221533-4406%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22B2JSS4XR%22%2C%22DF5KVMFT%22%2C%22N5HQ4VYL%22%5D%2C%22dateModified%22%3A%222022-03-08T19%3A33%3A38Z%22%7D%7D%5D%7D
Kiang, S., Nissim, L., Tedesco, V. et al. (2022). Modeling a magnetic levitation bearing with CFD hemocompatibility optimization. In 2022 IEEE 20th Biennial Conference on Electromagnetic Field Computation (CEFC) (1–2). Denver, CO, USA: IEEE. https://doi.org/10.1109/CEFC55061.2022.9940768.
Cocha, G., Tedesco, V., D’Attellis, C. et al. (2021). An algorithm mimicking pancreas pulsatile behavior improves artificial pancreas performance. Int J Artif Organs 44, 756–764. https://doi.org/10.1177/03913988211027176.
Tedesco, V. E. and Mohan, C. (2021). Biomarkers for Predicting Cytokine Release Syndrome following CD19-Targeted CAR T Cell Therapy. J Immunol 206, 1561–1568. https://doi.org/10.4049/jimmunol.2001249.
Tedesco, A. E. and Tedesco, V. E. (2017). Pledget Induced Cardiogenic Shock Following a Minimally Invasive Aortic Valve Replacement. J La State Med Soc 169, 94–95
Reardon, M. J., Van Mieghem, N. M., Popma, J. J. et al. (2017). Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 376, 1321–1331. https://doi.org/10.1056/NEJMoa1700456.
Popma, J. J., Adams, D. H., Reardon, M. J. et al. (2014). Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63, 1972–1981. https://doi.org/10.1016/j.jacc.2014.02.556.
Adams, D. H., Popma, J. J., Reardon, M. J. et al. (2014). Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370, 1790–1798. https://doi.org/10.1056/NEJMoa1400590.